<SEC-DOCUMENT>0001558370-24-005018-index.html : 20240412
<SEC-HEADER>0001558370-24-005018.hdr.sgml : 20240412
<ACCEPTANCE-DATETIME>20240412160628
ACCESSION NUMBER:		0001558370-24-005018
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		12
FILED AS OF DATE:		20240412
DATE AS OF CHANGE:		20240412

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeuroBo Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-278646
		FILM NUMBER:		24841474

	BUSINESS ADDRESS:	
		STREET 1:		545 CONCORD AVENUE
		STREET 2:		SUITE 210
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138
		BUSINESS PHONE:		(857) 702-9600

	MAIL ADDRESS:	
		STREET 1:		545 CONCORD AVENUE
		STREET 2:		SUITE 210
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
		DATE OF NAME CHANGE:	20150331
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>tmb-20240412xs3.htm
<DESCRIPTION>S-3
<TEXT>
Document 1 - file: tmb-20240412xs3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3.6 <SEQUENCE>2 <FILENAME>tmb-20240412xex3d6.htm <DESCRIPTION>EX-3.6 <TEXT> Document 2 - file: tmb-20240412xex3d6.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.3 <SEQUENCE>3 <FILENAME>tmb-20240412xex4d3.htm <DESCRIPTION>EX-4.3 <TEXT> Document 3 - file: tmb-20240412xex4d3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.5 <SEQUENCE>4 <FILENAME>tmb-20240412xex4d5.htm <DESCRIPTION>EX-4.5 <TEXT> Document 4 - file: tmb-20240412xex4d5.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.6 <SEQUENCE>5 <FILENAME>tmb-20240412xex4d6.htm <DESCRIPTION>EX-4.6 <TEXT> Document 5 - file: tmb-20240412xex4d6.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.7 <SEQUENCE>6 <FILENAME>tmb-20240412xex4d7.htm <DESCRIPTION>EX-4.7 <TEXT> Document 6 - file: tmb-20240412xex4d7.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>7 <FILENAME>tmb-20240412xex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 7 - file: tmb-20240412xex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>8 <FILENAME>tmb-20240412xex23d1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 8 - file: tmb-20240412xex23d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>9 <FILENAME>tmb-20240412xexfilingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 9 - file: tmb-20240412xexfilingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>tmb-20240412xex5d1002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 10 - file: tmb-20240412xex5d1002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>tmb-20240412xs3003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 11 - file: tmb-20240412xs3003.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>12 <FILENAME>tmb-20240412xs3010.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 12 - file: tmb-20240412xs3010.jpg
</DOCUMENT> </SEC-DOCUMENT>